Guanine nucleotide-binding protein 1 is one of the key molecules contributing to cancer cell radioresistance

Cancer Science

Volumn 105, Issue 10, 2014, Pages 1351-1359

  Fukumoto, Motoi ^a   Amanuma, Tatsuya ^a   Kuwahara, Yoshikazu ^a   Shimura, Tsutomu ^a   Suzuki, Masatoshi ^a   Mori, Shiro ^a   Kumamoto, Hiroyuki ^a   Saito, Yohei ^b   Ohkubo, Yasuhito ^b   Duan, Zhenfeng ^c   Sano, Kenji ^d   Oguchi, Tomohiro ^d   Kainuma, Kazuyuki ^d   Usami, Shinichi ^d   Kinoshita, Kengo ^a   Lee, Inchul ^e   Fukumoto, Manabu ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b TOHOKU PHARMACEUTICAL UNIVERSITY   (Japan)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e Asan Medical Center   (South Korea)

Author keywords

GTP binding proteins; Head and neck neoplasms; Neoplasms; Radiation; Radiation oncology

Indexed keywords

GBP1 PROTEIN, HUMAN; GUANINE NUCLEOTIDE BINDING PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; POU5F1 PROTEIN, HUMAN;

AGED; ANIMAL; CANCER STEM CELL; DNA MICROARRAY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MOUSE; NEOPLASMS; PATHOLOGY; PHYSIOLOGY; RADIATION DOSE; RADIATION RESPONSE; TUMOR CELL LINE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANIMALS; CELL LINE, TUMOR; FEMALE; GTP-BINDING PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MIDDLE AGED; NEOPLASMS; NEOPLASTIC STEM CELLS; OCTAMER TRANSCRIPTION FACTOR-3; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RADIATION TOLERANCE;

EID: 84911061353     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/cas.12489     Document Type: Article

References (30)

1. Tannock I. The Basic Science of Oncology, 4th edn. New York, NY: McGraw-Hill, Medical Publications, 2005.
2. Kuwahara Y, Li L, Baba T et al. Clinically relevant radioresistant cells efficiently repair DNA double-strand breaks induced by X-rays. Cancer Sci 2009; 100: 747-52.
3. Shimura T, Kakuda S, Ochiai Y et al. Acquired radioresistance of human tumor cells by DNA-PK/AKT/GSK3beta-mediated cyclin D1 overexpression. Oncogene 2010; 29: 4826-37.
4. Naschberger E, Bauer M, Sturzl M. Human guanylate binding protein-1 (hGBP-1) characterizes and establishes a non-angiogenic endothelial cell activation phenotype in inflammatory diseases. Adv Enzyme Regul 2005; 45: 215-27.
5. Olszewski MA, Gray J, Vestal DJ. In silico genomic analysis of the human and murine guanylate-binding protein (GBP) gene clusters. J Interferon Cytokine Res 2006; 26: 328-52.
6. Cheng YS, Colonno RJ, Yin FH. Interferon induction of fibroblast proteins with guanylate binding activity. J Biol Chem 1983; 258: 7746-50.
7. Guenzi E, Topolt K, Cornali E et al. The helical domain of GBP-1 mediates the inhibition of endothelial cell proliferation by inflammatory cytokines. EMBO J 2001; 20: 5568-77.
8. Guenzi E, Topolt K, Lubeseder-Martellato C et al. The guanylate binding protein-1 GTPase controls the invasive and angiogenic capability of endothelial cells through inhibition of MMP-1 expression. EMBO J 2003; 22: 3772-82.
9. Lubeseder-Martellato C, Guenzi E, Jorg A et al. Guanylate-binding protein-1 expression is selectively induced by inflammatory cytokines and is an activation marker of endothelial cells during inflammatory diseases. Am J Pathol 2002; 161: 1749-59.
10. Itsui Y, Sakamoto N, Kurosaki M et al. Expressional screening of interferon-stimulated genes for antiviral activity against hepatitis C virus replication. J Viral Hepat 2006; 13: 690-700.
11. Pammer J, Reinisch C, Birner P, Pogoda K, Sturzl M, Tschachler E. Interferon-alpha prevents apoptosis of endothelial cells after short-term exposure but induces replicative senescence after continuous stimulation. Lab Invest 2006; 86: 997-1007.
12. De Donato M, Mariani M, Petrella L et al. Class III beta-tubulin and the cytoskeletal gateway for drug resistance in ovarian cancer. J Cell Physiol 2012; 227: 1034-41.
13. Duan Z, Foster R, Brakora KA, Yusuf RZ, Seiden MV. GBP1 overexpression is associated with a paclitaxel resistance phenotype. Cancer Chemother Pharmacol 2006; 57: 25-33.
14. Yu CJ, Chang KP, Chang YJ et al. Identification of guanylate-binding protein 1 as a potential oral cancer marker involved in cell invasion using omics-based analysis. J Proteome Res 2011; 10: 3778-88.
15. Kuwahara Y, Mori M, Oikawa T et al. The modified high-density survival assay is the useful tool to predict the effectiveness of fractionated radiation exposure. J Radiat Res 2010; 51: 297-302.
16. Kuwahara Y, Oikawa T, Ochiai Y et al. Enhancement of autophagy is a potential modality for tumors refractory to radiotherapy. Cell Death Dis 2011; 2: e177.
17. Hao Y, Yang D. Cloning, eukaryotic expression of human ISG20 and preliminary study on the effect of its anti-HBV. J Huazhong Univ Sci Technolog Med Sci 2008; 28: 11-3.
18. Suzuki M, Suzuki K, Kodama S, Watanabe M. Phosphorylated histone H2AX foci persist on rejoined mitotic chromosomes in normal human diploid cells exposed to ionizing radiation. Radiat Res 2006; 165: 269-76.
19. Toda Y, Kono K, Abiru H et al. Application of tyramide signal amplification system to immunohistochemistry: a potent method to localize antigens that are not detectable by ordinary method. Pathol Int 1999; 49: 479-83.
20. Shimura T, Noma N, Oikawa T et al. Activation of the AKT/cyclin D1/Cdk4 survival signaling pathway in radioresistant cancer stem cells. Oncogenesis 2012; 1: e12.
21. Utsumi H, Elkind MM. Requirement for repair of DNA double-strand breaks by homologous recombination in split-dose recovery. Radiat Res 2001; 155: 680-6.
22. Shibata A, Moiani D, Arvai AS et al. DNA double-strand break repair pathway choice is directed by distinct MRE11 nuclease activities. Mol Cell 2014; 53: 7-18.
23. Kawasaki K, Maruyama S, Nakayama M, Matsumoto K, Shibata T. Drosophila melanogaster RECQ5/QE DNA helicase: stimulation by GTP binding. Nucleic Acids Res 2002; 30: 3682-91.
24. Schnoor M, Betanzos A, Weber DA, Parkos CA. Guanylate-binding protein-1 is expressed at tight junctions of intestinal epithelial cells in response to interferon-gamma and regulates barrier function through effects on apoptosis. Mucosal Immunol 2009; 2: 33-42.
25. Shimura T, Kakuda S, Ochiai Y, Kuwahara Y, Takai Y, Fukumoto M. Targeting the AKT/GSK3beta/cyclin D1/Cdk4 survival signaling pathway for eradication of tumor radioresistance acquired by fractionated radiotherapy. Int J Radiat Oncol Biol Phys 2011; 80: 540-8.
26. Lipnik K, Naschberger E, Gonin-Laurent N et al. Interferon gamma-induced human guanylate binding protein 1 inhibits mammary tumor growth in mice. Mol Med 2010; 16: 177-87.
27. Naschberger E, Croner RS, Merkel S et al. Angiostatic immune reaction in colorectal carcinoma: impact on survival and perspectives for antiangiogenic therapy. Int J Cancer 2008; 123: 2120-9.
28. Desarnaud F, Geck P, Parkin C, Carpinito G, Makarovskiy AN. Gene expression profiling of the androgen independent prostate cancer cells demonstrates complex mechanisms mediating resistance to docetaxel. Cancer Biol Ther 2011; 11: 204-12.
29. Schwemmle M, Staeheli P. The interferon-induced 67-kDa guanylate-binding protein (hGBP1) is a GTPase that converts GTP to GMP. J Biol Chem 1994; 269: 11299-305.
30. Praefcke GJ, Geyer M, Schwemmle M. Robert Kalbitzer H, Herrmann C. Nucleotide-binding characteristics of human guanylate-binding protein 1 (hGBP1) and identification of the third GTP-binding motif. J Mol Biol 1999; 292: 321-32.